Use of probiotics in patients with Parkinson's disease: the importance of the gut-brain axis and dietotherapy – a literature review

Authors

DOI:

https://doi.org/10.33448/rsd-v9i9.7259

Keywords:

Parkinson's disease; Probiotics; Microbiota; Neuroimmunomodulation; Dietotherapy.

Abstract

Parkinson's disease (PD) is the second most common degenerative disease of the central nervous system affecting between 1 and 2 people in 1,000 and its prevalence increases with age, affecting about 1% of the population over 60 years. Studies in the bidirectional communication between the brain and the intestine have shown that changes in the intestinal microbiota can potentially play an important role in PD and have reported gastrointestinal symptoms (constipation, dysphagia, hypersalivation and swallowing disorders). Current evidence suggests that the health and composition of the intestinal microbiome are due to the effect of diet and the use of probiotics. This study aimed to evaluate the use of probiotics and nutritional therapy for PD. The literature search was performed using the PICoS criterion to extract evidence of relevant studies from articles published in PubMed, ScienceDirect, and MEDLINE, selecting only articles with randomized clinical studies and reviews. Even with a limited number of quality studies in humans, we found research that highlighted the importance of using probiotics and diet in patients with PD, as it brings benefits to gastrointestinal motility, contributes to the symbiosis of GIT and improves stool consistency. It is concluded that the use of probiotics is a good intervention method for patients with PD. Future research should focus on the gut-brain axis and investigate how microbial populations exert pathogenic effects, as well as their interaction with diets and medications.

References

Agarwal, P., Wang, Y., Buchman, A. S., Holland, T. M., Bennett, D. A., & Morris, M. C. (2018). MIND Diet Associated with Reduced Incidence and Delayed Progression of Parkinsonism in Old Age. Journal of Nutrition, Health and Aging, 22(10), 1211–1215. https://doi.org/10.1007/s12603-018-1094-5

Arentsen, T., Qian, Y., Gkotzis, S., Femenia, T., Wang, T., Udekwu, K., Forssberg, H., & Diaz Heijtz, R. (2017). The bacterial peptidoglycan-sensing molecule Pglyrp2 modulates brain development and behavior. Molecular psychiatry, 22(2), 257–266. https://doi.org/10.1038/mp.2016.182

Baars, A., Oosting, A., Lohuis, M., Koehorst, M., El Aidy, S., Hugenholtz, F., Fransen, F. (2018). Sex differences in lipid metabolism are affected by presence of the gut microbiota. Scientific Reports, 8(1), 1–11. https://doi.org/10.1038/s41598-018-31695-w

Barboza, J. L., Okun, M. S., & Moshiree, B. (2015, November 2). The treatment of gastroparesis, constipation and small intestinal bacterial overgrowth syndrome in patients with Parkinsons disease. Expert Opinion on Pharmacotherapy. Taylor and Francis Ltd. https://doi.org/10.1517/14656566.2015.1086747

Barichella, M., Pacchetti, C., Bolliri, C., Cassani, E., Iorio, L., Pusani, C., Cereda, E. (2016). Probiotics and prebiotic fiber for constipation associated with Parkinson disease. Neurology, 87(12), 1274–1280. https://doi.org/10.1212/WNL.0000000000003127

Bercik, P., Denou, E., Collins, J., Jackson, W., Lu, J., Jury, J., Collins, S. M. (2011). The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology, 141(2). https://doi.org/10.1053/j.gastro.2011.04.052

Borzabadi, S., Oryan, S., Eidi, A., Aghadavod, E., Kakhaki, R. D., Tamtaji, O. R., Asemi, Z. (2018). The effects of probiotic supplementation on gene expression related to inflammation, insulin and lipid in patients with Parkinson’s disease: A randomized, double-blind, placebo-controlled trial. Archives of Iranian Medicine, 21(7), 289–295. https://doi: 10.1080/07315724.2017.1347074

Burgos, R., Bretón, I., Cereda, E., Desport, J. C., Dziewas, R., Genton, L., Bischoff, S. C. (2018). ESPEN guideline clinical nutrition in neurology. Clinical Nutrition, 37(1), 354–396. https://doi.org/10.1016/j.clnu.2017.09.003

Cassani, E., Privitera, G., Pezzoli, G., Pusani, C., Madio, C., Iorio, L., & Barichella, M. (2011). Use of probiotics for the treatment of constipation in Parkinson’s disease patients. Minerva Gastroenterologica e Dietologica, 57(2), 117–121. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/21587143

Chen, R. C., Chang, S. F., Su, C. L., Chen, T. H. H., Yen, M. F., Wu, H. M., Liou, H. H. (2001). Prevalence, incidence, and mortality of PD: A door-to-door survey in Ilan County, Taiwan. Neurology, 57(9), 1679–1686. https://doi.org/10.1212/WNL.57.9.1679

Chenoll, E., Casinos, B., Bataller, E., Astals, P., Echevarría, J., Iglesias, J. R., Genovés, S. (2011). Novel probiotic Bifidobacterium bifidum CECT 7366 strain active against the pathogenic bacterium Helicobacter pylori. Applied and Environmental Microbiology, 77(4), 1335–1343. https://doi.org/10.1128/AEM.01820-10

Chung, H.-J., Sim, J.-H., Min, T.-S., & Choi, H.-K. (2018). Metabolomics and Lipidomics Approaches in the Science of Probiotics: A Review. Journal of Medicinal Food, 21(11), 1086–1095. https://doi.org/10.1089/jmf.2017.4175

Comi, C., & Tondo, G. (2017, January 1). Insights into the protective role of immunity in neurodegenerative disease. Neural Regeneration Research. Editorial Board of Neural Regeneration Research. https://doi.org/10.4103/1673-5374.198980

Cryan, J. F., O’Riordan, K. J., Sandhu, K., Peterson, V., & Dinan, T. G. (2020, February 1). The gut microbiome in neurological disorders. The Lancet Neurology. Lancet Publishing Group. https://doi.org/10.1016/S1474-4422(19)30356-4

Cussotto, S., Sandhu, K. V., Dinan, T. G., & Cryan, J. F. (2018, October 1). The Neuroendocrinology of the Microbiota-Gut-Brain Axis: A Behavioural Perspective. Frontiers in Neuroendocrinology. Academic Press Inc. https://doi.org/10.1016/j.yfrne.2018.04.002

Dalile, B., Van Oudenhove, L., Vervliet, B., & Verbeke, K. (2019, August 1). The role of short-chain fatty acids in microbiota–gut–brain communication. Nature Reviews Gastroenterology and Hepatology. Nature Publishing Group. https://doi.org/10.1038/s41575-019-0157-3

Del Tredici, K., Rüb, U., Vos, R. A. I. De, Bohl, J. R. E., & Braak, H. (2002). Where Does Parkinson Disease Pathology Begin in the Brain? Journal of Neuropathology and Experimental Neurology, 61(5). https://doi.org/10.1093/JNEN/61.5.413

Dinan, T. G., & Cryan, J. F. (2017, March 1). The Microbiome-Gut-Brain Axis in Health and Disease. Gastroenterology Clinics of North America. W.B. Saunders. https://doi.org/10.1016/j.gtc.2016.09.007

Dutta, S. K., Verma, S., Jain, V., Surapaneni, B. K., Vinayek, R., Phillips, L., & Nair, P. P. (2019). Parkinson’s disease: The emerging role of gut dysbiosis, antibiotics, probiotics, and fecal microbiota transplantation. Journal of Neurogastroenterology and Motility. Korean Society of Neurogastroenterology and Motility. https://doi.org/10.5056/jnm19044

Fang, X. (2019, January 1). Microbial treatment: the potential application for Parkinson’s disease. Neurological Sciences. Springer-Verlag Italia s.r.l. https://doi.org/10.1007/s10072-018-3641-6

Fasano, A., Visanji, N. P., Liu, L. W. C., Lang, A. E., & Pfeiffer, R. F. (2015, June 1). Gastrointestinal dysfunction in Parkinson’s disease. The Lancet Neurology. Lancet Publishing Group. https://doi.org/10.1016/S1474-4422(15)00007-1

Forsyth, C. B., Shannon, K. M., Kordower, J. H., Voigt, R. M., Shaikh, M., Jaglin, J. A., Keshavarzian, A. (2011). Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson’s disease. PLoS ONE, 6(12). https://doi.org/10.1371/journal.pone.0028032

Franzosa, E. A., Huang, K., Meadow, J. F., Gevers, D., Lemon, K. P., Bohannan, B. J. M., & Huttenhower, C. (2015). Identifying personal microbiomes using metagenomic codes. Proceedings of the National Academy of Sciences of the United States of America, 112(22), E2930–E2938. https://doi.org/10.1073/pnas.1423854112

Fülling, C., Dinan, T. G., & Cryan, J. F. (2019, March 20). Gut Microbe to Brain Signaling: What Happens in Vagus…. Neuron. Cell Press. https://doi.org/10.1016/j.neuron.2019.02.008

Gao, K., Pi, Y., Mu, C., Farzi, A., Liu, Z., & Zhu, W. (2019). Increasing carbohydrate availability in the hindgut promotes hypothalamic neurotransmitter synthesis: aromatic amino acids linking the microbiota–brain axis. Journal of Neurochemistry, 149(5), 641–659. https://doi.org/10.1111/jnc.14709

Gazerani, P. (2019, September 1). Probiotics for Parkinson’s disease. International Journal of Molecular Sciences. MDPI AG. https://doi.org/10.3390/ijms20174121

Georgescu, D., Ancusa, O., Georgescu, L., Ionita, I., & Reisz, D. (2016). Nonmotor gastrointestinal disorders in older patients with Parkinson's disease: is there hope? Clinical Interventions in Aging, Volume 11, 1601–1608. https://doi.org/10.2147/CIA.S106284

Ghaisas, S., Maher, J., & Kanthasamy, A. (n.d.). Gut microbiome in health and disease: linking the microbiome-gut-brain axis and environmental factors in the pathogenesis of systemic and neurodegenerative diseases. https://doi.org/10.1016/j.pharmthera.2015.11.012

Ghaisas, S., Maher, J., & Kanthasamy, A. (2016, February 1). Gut microbiome in health and disease: Linking the microbiome-gut-brain axis and environmental factors in the pathogenesis of systemic and neurodegenerative diseases. Pharmacology and Therapeutics. Elsevier Inc. https://doi.org/10.1016/j.pharmthera.2015.11.012

Girolamo, F., Coppola, C., & Ribatti, D. (2017). Immunoregulatory effect of mast cells influenced by microbes in neurodegenerative diseases. Brain, Behavior, and Immunity, 65, 68–89. https://doi.org/10.1016/j.bbi.2017.06.017

Goodrich, J. K., Davenport, E. R., Waters, J. L., Clark, A. G., & Ley, R. E. (2016, April 29). Cross-species comparisons of host genetic associations with the microbiome. Science. American Association for the Advancement of Science. https://doi.org/10.1126/science.aad9379

Gomes, P. C., & Maynard, D. da C. (2020). Relação entre o hábito alimentar, consumo de probiótico e prebiótico no perfil da microbiota intestinal: Revisão integrativa. Research, Society and Development, 9(8), e718986101. https://doi.org/10.33448/rsd-v9i8.6101

Grzeskowiak, L., Collado, M. C., Mangani, C., Maleta, K., Laitinen, K., Ashorn, P., Salminen, S. (2012). Distinct Gut microbiota in southeastern African and northern European infants. Journal of Pediatric Gastroenterology and Nutrition, 54(6), 812–816. https://doi.org/10.1097/MPG.0b013e318249039c

Hiller, A. L., Murchison, C. F., Lobb, B. M., O’Connor, S., O’Connor, M., & Quinn, J. F. (2018). A randomized, controlled pilot study of the effects of vitamin D supplementation on balance in Parkinson’s disease: Does age matter? PLoS ONE, 13(9). https://doi.org/10.1371/journal.pone.0203637

Holzer, P., Farzi, A., Hassan, A. M., Zenz, G., Jacan, A., & Reichmann, F. (2017, November 22). Visceral inflammation and immune activation stress the brain. Frontiers in Immunology. Frontiers Media S.A. https://doi.org/10.3389/fimmu.2017.01613

Kalampokini, S., Becker, A., Fassbender, K., Lyros, E., & Unger, M. (2019). Nonpharmacological Modulation of Chronic Inflammation in Parkinson’s Disease: Role of Diet Interventions. Parkinson’s Disease, 2019. https://doi.org/10.1155/2019/7535472

Keshavarzian, A., Green, S. J., Engen, P. A., Voigt, R. M., Naqib, A., Forsyth, C. B., Shannon, K. M. (2015). Colonic bacterial composition in Parkinson’s disease. Movement Disorders, 30(10), 1351–1360. https://doi.org/10.1002/mds.26307

Kim, N., Yun, M., Oh, Y. J., & Choi, H. J. (2018, March 1). Mind-altering with the gut: Modulation of the gut-brain axis with probiotics. Journal of Microbiology. Microbiological Society of Korea. https://doi.org/10.1007/s12275-018-8032-4

Kouli, A., Torsney, K. M., & Kuan, W.-L. (2018). Parkinson’s Disease: Etiology, Neuropathology, and Pathogenesis. In Parkinson’s Disease: Pathogenesis and Clinical Aspects (pp.3–26). Codon Publications. https://doi.org/10.15586/codonpublications.parkinsonsdisease.2018.ch1

Kraeuter, A. K., Phillips, R., & Sarnyai, Z. (2020, July 13). Ketogenic therapy in neurodegenerative and psychiatric disorders: From mice to men. Progress in Neuro-Psychopharmacology and Biological Psychiatry. Elsevier Inc. https://doi.org/10.1016/j.pnpbp.2020.109913

Kujawska, M., & Jodynis-Liebert, J. (2018, November 12). What is the evidence that parkinson’s disease is a prion disorder, which originates in the gut? International Journal of Molecular Sciences. MDPI AG. https://doi.org/10.3390/ijms19113573

Lange, K. W., Nakamura, Y., Chen, N., Guo, J., Kanaya, S., Lange, K. M., & Li, S. (2019, June 1). Diet and medical foods in Parkinson’s disease. Food Science and Human Wellness. Elsevier B.V. https://doi.org/10.1016/j.fshw.2019.03.006

Lin, C. H., Chen, C. C., Chiang, H. L., Liou, J. M., Chang, C. M., Lu, T. P., Wu, M. S. (2019). Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson’s disease. Journal of Neuroinflammation, 16(1). https://doi.org/10.1186/s12974-019-1528-y

Liu, D., Ke, Z., & Luo, J. (2017, September 1). Thiamine Deficiency and Neurodegeneration: the Interplay Among Oxidative Stress, Endoplasmic Reticulum Stress, and Autophagy. Molecular Neurobiology. Humana Press Inc. https://doi.org/10.1007/s12035-016-0079-9

Liu, Y., & Zhang, B. S. (2014). Serum 25-hydroxyvitamin D predicts severity in Parkinson’s disease patients. Neurological Sciences, 35(1), 67–71. https://doi.org/10.1007/s10072-013-1539-x

Lombardi, V. C., De Meirleir, K. L., Subramanian, K., Nourani, S. M., Dagda, R. K., Delaney, S. L., & Palotás, A. (2018, November 1). Nutritional modulation of the intestinal microbiota: future opportunities for the prevention and treatment of neuroimmune and neuroinflammatory disease. Journal of Nutritional Biochemistry. Elsevier Inc. https://doi.org/10.1016/j.jnutbio.2018.04.004

Marietta, E., Horwath, I., & Taneja, V. (2018, January 1). Microbiome, Immunomodulation, and the Neuronal System. Neurotherapeutics. Springer New York LLC. https://doi.org/10.1007/s13311-017-0601-4

Martin, C. R., Osadchiy, V., Kalani, A., & Mayer, E. A. (2018, January 1). The Brain-Gut-Microbiome Axis. CMGH. Elsevier Inc. https://doi.org/10.1016/j.jcmgh.2018.04.003

McCarty, M. F., & Lerner, A. (2020). Nutraceuticals Targeting Generation and Oxidant Activity of Peroxynitrite May Aid Prevention and Control of Parkinson’s Disease. International Journal of Molecular Sciences, 21(10), 3624. https://doi.org/10.3390/ijms21103624

Mertsalmi, T. H., Aho, V. T. E., Pereira, P. A. B., Paulin, L., Pekkonen, E., Auvinen, P., & Scheperjans, F. (2017). More than constipation – bowel symptoms in Parkinson’s disease and their connection to gut microbiota. European Journal of Neurology, 24(11), 1375–1383. https://doi.org/10.1111/ene.13398

Minato, T., Maeda, T., Fujisawa, Y., Tsuji, H., Nomoto, K., Ohno, K., & Hirayama, M. (2017). Progression of Parkinson’s disease is associated with gut dysbiosis: Two-year follow-up study. PLoS ONE, 12(11). https://doi.org/10.1371/journal.pone.0187307

Mozaffari, S., Nikfar, S., Daniali, M., & Abdollahi, M. (2020, April 12). The pharmacological management of constipation in patients with Parkinson’s disease: a much-needed relief. Expert Opinion on Pharmacotherapy. Taylor and Francis Ltd. https://doi.org/10.1080/14656566.2020.1726319

Mukherjee, A., Biswas, A., & Das, S. K. (2016, July 7). Gut dysfunction in Parkinson’s disease. World Journal of Gastroenterology. Baishideng Publishing Group Co., Limited. https://doi.org/10.3748/wjg.v22.i25.5742

Noyce, A. J., Bestwick, J. P., Silveira-Moriyama, L., Hawkes, C. H., Giovannoni, G., Lees, A. J., & Schrag, A. (2012, December). Meta-analysis of early nonmotor features and risk factors for Parkinson disease. Annals of Neurology. Ann Neurol. https://doi.org/10.1002/ana.23687

Olanow, C. W., Klein, C., & Schapira, A. H. V. (2020). Parkinson’s Disease | Harrison’s Principles of Internal Medicine| AccessMedicine | McGraw-Hill Medical. Retrieved June 21, 2020. Retrieved from https://accessmedicine.mhmedical.com/content.aspx?bookid=2129&sectionid=192532363

Parashar, A., & Udayabanu, M. (2017, May 1). Gut microbiota: Implications in Parkinson’s disease. Parkinsonism and Related Disorders. Elsevier Ltd. https://doi.org/10.1016/j.parkreldis.2017.02.002

Parkinson, J. (2002). An Essay on the Shaking Palsy. J Neuropsychiatry Clin Neurosci (Vol. 14). https://doi.org/10.1176/jnp.14.2.223

Pascale, A., Marchesi, N., Govoni, S., & Barbieri, A. (2020, July 1). Targeting the microbiota in pharmacology of psychiatric disorders. Pharmacological Research. Academic Press. https://doi.org/10.1016/j.phrs.2020.104856

Perez-Pardo, P., Dodiya, H. B., Broersen, L. M., Douna, H., van Wijk, N., Lopes da Silva, S., Kraneveld, A. D. (2018). Gut–brain and brain–gut axis in Parkinson’s disease models: Effects of a uridine and fish oil diet. Nutritional Neuroscience, 21(6), 391–402. https://doi.org/10.1080/1028415X.2017.1294555

Petticrew, M., & Roberts, H. (2006). M. Petticrew and H. Roberts. Systematic Reviews in the Social Sciences: A Practical Guide. Counselling and Psychotherapy Research, 6(4), 304–305. https://doi.org/10.1080/14733140600986250

Phillips, M. C. L., Murtagh, D. K. J., Gilbertson, L. J., Asztely, F. J. S., & Lynch, C. D. P. (2018). Low-fat versus ketogenic diet in Parkinson’s disease: A pilot randomized controlled trial. Movement Disorders, 33(8), 1306–1314. https://doi.org/10.1002/mds.27390

Pierantozzi, M., Pietroiusti, A., Sancesario, G., Lunardi, G., Fedele, E., Giacomini, P., Stanzione, P. (2001). Reduced L-dopa absorption and increased clinical fluctuations in Helicobacter pylori-infected Parkinson’s disease patients. In Neurological Sciences (Vol. 22, pp. 89–91). Neurol Sci. https://doi.org/10.1007/s100720170061

Quigley, E. M. M. (2017, December 1). Microbiota-Brain-Gut Axis and Neurodegenerative Diseases. Current Neurology and Neuroscience Reports. Current Medicine Group LLC 1. https://doi.org/10.1007/s11910-017-0802-6

Rimmelzwaan, L. M., Van Schoor, N. M., Lips, P., Berendse, H. W., & Eekhoff, E. M. W. (2016, March 30). Systematic Review of the Relationship between Vitamin D and Parkinson’s Disease. Journal of Parkinson’s Disease. IOS Press. https://doi.org/10.3233/JPD-150615

Sánchez, B., Delgado, S., Blanco-Míguez, A., Lourenço, A., Gueimonde, M., & Margolles, A. (2017). Probiotics, gut microbiota, and their influence on host health and disease. Molecular Nutrition & Food Research, 61(1), 1600240. https://doi.org/10.1002/mnfr.201600240

Santos, S. F., De Oliveira, H. L., Yamada, E. S., Neves, B. C., & Pereira, A. (2019, June 4). The gut and Parkinson’s disease - A bidirectional pathway. Frontiers in Neurology. Frontiers Media S.A. https://doi.org/10.3389/fneur.2019.00574

Sasmita, A. O. (2019). Modification of the gut microbiome to combat neurodegeneration. Reviews in the Neurosciences, 30(8). https://doi.org/10.1515/revneuro-2019-0005

Scheperjans, F., Aho, V., Pereira, P. A. B., Koskinen, K., Paulin, L., Pekkonen, E., Auvinen, P. (2015). Gut microbiota are related to Parkinson’s disease and clinical phenotype. Movement Disorders, 30(3), 350–358. https://doi.org/10.1002/mds.26069

Shen, L. (2015). Associations between B Vitamins and Parkinson’s Disease. Nutrients, 7(9), 7197–7208. https://doi.org/10.3390/nu7095333

Soto, M., Herzog, C., Pacheco, J. A., Fujisaka, S., Bullock, K., Clish, C. B., & Kahn, C. R. (2018). Gut microbiota modulate neurobehavior through changes in brain insulin sensitivity and metabolism. Molecular Psychiatry, 23(12), 2287–2301. https://doi.org/10.1038/s41380-018-0086-5

Spielman, L. J., Gibson, D. L., & Klegeris, A. (2018, November 1). Unhealthy gut, unhealthy brain: The role of the intestinal microbiota in neurodegenerative diseases. Neurochemistry International. Elsevier Ltd. https://doi.org/10.1016/j.neuint.2018.08.005

Sureda, A., del Mar Bibiloni, M., Julibert, A., Bouzas, C., Argelich, E., Llompart, I., … Tur, J. A. (2018). Adherence to the mediterranean diet and inflammatory markers. Nutrients, 10(1). https://doi.org/10.3390/nu10010062

Tamtaji, O. R., Taghizadeh, M., Daneshvar Kakhaki, R., Kouchaki, E., Bahmani, F., Borzabadi, S., Asemi, Z. (2019). Clinical and metabolic response to probiotic administration in people with Parkinson’s disease: A randomized, double-blind, placebo-controlled trial. Clinical Nutrition, 38(3), 1031–1035. https://doi.org/10.1016/j.clnu.2018.05.018

Tysnes, O. B., & Storstein, A. (2017, August 1). Epidemiology of Parkinson’s disease. Journal of Neural Transmission. Springer-Verlag Wien. https://doi.org/10.1007/s00702-017-1686-y

Uyar, G. Ö., & Yildiran, H. (2019). A nutritional approach to microbiota in Parkinson’s disease. Bioscience of Microbiota, Food and Health. BMFH Press. https://doi.org/10.12938/bmfh.19-002

Vernocchi, P., Del Chierico, F., & Putignani, L. (2016, July 26). Gut microbiota profiling: Metabolomics based approach to unravel compounds affecting human health. Frontiers in Microbiology. Frontiers Media S.A. https://doi.org/10.3389/fmicb.2016.01144

Westfall, S., Lomis, N., Kahouli, I., Dia, S. Y., Singh, S. P., & Prakash, S. (2017, October 1). Microbiome, probiotics and neurodegenerative diseases: deciphering the gut brain axis. Cellular and Molecular Life Sciences. Birkhauser Verlag AG. https://doi.org/10.1007/s00018-017-2550-9

WHO, & FAO. (2001). Probiotics in food Health and nutritional properties and guidelines for evaluation FAO FOOD AND NUTRITION PAPER. Probiotics in Food, 2. Retrieved from http://www.fao.org/3/a-a0512e.pdf

Yarandi, S. S., Peterson, D. A., Treisman, G. J., Moran, T. H., & Pasricha, P. J. (2016, April 1). Modulatory effects of gut microbiota on the central nervous system: How gut could play a role in neuropsychiatric health and diseases. Journal of Neurogastroenterology and Motility. Journal of Neurogastroenterology and Motility. https://doi.org/10.5056/jnm15146

Zwickey, H., Lipski, L., Wu, W., Kong, Q., Tian, P., Zhai, Q., Kunugi, H. (2018). Nutritional modulation of the intestinal microbiota: future opportunities for the prevention and treatment of neuroimmune and neuroinflammatory disease. Journal of Nutritional Biochemistry, 19(3), 1–16. https://doi.org/10.1016/j.jnutbio.2018.04.004

Published

21/08/2020

How to Cite

Santos , R. B. ., Anjos, H. A. dos ., Ribeiro , T. T. ., & Correia , V. D. D. M. R. . (2020). Use of probiotics in patients with Parkinson’s disease: the importance of the gut-brain axis and dietotherapy – a literature review. Research, Society and Development, 9(9), e357997259. https://doi.org/10.33448/rsd-v9i9.7259

Issue

Section

Health Sciences